Magnesium lithospermate B, an active extract of salvia miltiorrhiza, mediates SGC/CGMP/PKG translocation in experimental vasospasm

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Chang, Chih Zen ^a,b,c   Wu, Shu Chuan ^b   Kwan, Aij Lie ^a,b  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c KAOHSIUNG MUNICIPAL TA TUNG HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC GMP; GUANYLATE CYCLASE; MAGNESIUM LITHOSPERMATE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PROTEIN KINASE C DELTA; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SOLUBLE GUANYLYL CYCLASE; SOLUBLE GUANYLYL CYCLASE ALPHA1; SOLUBLE GUANYLYL CYCLASE BETA1; UNCLASSIFIED DRUG; CELL RECEPTOR; CYCLIC GMP DEPENDENT PROTEIN KINASE; HERBACEOUS AGENT; LITHOSPERMATE B; SALVIA EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASILAR ARTERY; BRAIN VASOSPASM; CONTROLLED STUDY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; MALE; MUSCLE NECROSIS; NONHUMAN; PROTEIN EXPRESSION; RAT; RODENT; SALVIA MILTIORRHIZA; SMOOTH MUSCLE; SUBARACHNOID HEMORRHAGE; VASODILATATION; WESTERN BLOTTING; ACTIVE TRANSPORT; ANIMAL; CHEMISTRY; DISEASE MODEL; DRUG EFFECTS; METABOLISM; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; VASOSPASM, INTRACRANIAL;

ANIMALS; BIOLOGICAL TRANSPORT, ACTIVE; CYCLIC GMP; CYCLIC GMP-DEPENDENT PROTEIN KINASES; DISEASE MODELS, ANIMAL; DRUGS, CHINESE HERBAL; GUANYLATE CYCLASE; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SALVIA MILTIORRHIZA; SIGNAL TRANSDUCTION; VASOSPASM, INTRACRANIAL;

EID: 84899557463     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/272101     Document Type: Article

References (31)

1. Grasso G., An overview of new pharmacological treatments for cerebrovascular dysfunction after experimental subarachnoid hemorrhage. Brain Research Reviews 2004 44 1 49 63 2-s2.0-1642452712 10.1016/j.brainresrev.2003. 10.003 (Pubitemid 38114758)
2. Keyrouz S. G., Diringer M. N., Clinical review: prevention and therapy of vasospasm in subarachnoid hemorrhage. Critical Care 2007 11 4, article 220 2-s2.0-41049112320 10.1186/cc5958
3. Carter R. W., Begaye M., Kanagy N. L., Acute and chronic NOS inhibition enhances α 2-adrenoreceptor-stimulated RhoA and Rho kinase in rat aorta. The American Journal of Physiology-Heart and Circulatory Physiology 2002 283 4 H1361 H1369 2-s2.0-0036784012
4. Arrick D. M., Mayhan W. G., Inhibition of endothelin-1 receptors improves impaired nitric oxide synthase-dependent dilation of cerebral arterioles in type-1 diabetic rats. Microcirculation 2010 17 6 439 446 2-s2.0-77955260310 10.1111/j.1549-8719.2010.00042.x
5. 2+ sensitization of smooth muscle myosin II. The American Journal of Physiology-Cell Physiology 2001 281 1 C257 C269 2-s2.0-0034805388
6. Janssen L. J., Tazzeo T., Zuo J., Pertens E., Keshavjee S., KC1 evokes contraction of airway smooth muscle via activation of RhoA and Rho-kinase. The American Journal of Physiology-Lung Cellular and Molecular Physiology 2004 287 4 L852 L858 2-s2.0-4544323366 10.1152/ajplung.00130.2004 (Pubitemid 39249398)
7. Brandes R. P., Kim D. Y., Schmitz-Winnenthal F. H., Amidi M., Gödecke A., Mülsch A., Busse R., Increased nitrovasodilator sensitivity in endothelial nitric oxide synthase knockout mice: Role of soluble guanylyl cyclase. Hypertension 2000 35 1 231 236 2-s2.0-0033958234 (Pubitemid 30054178)
8. Duchemin S., Boily M., Sadekova N., Girouard H., The complex contribution of NOS interneurons in the physiology of cerebrovascular regulation. Front Neural Circuits 2012 6 51 1 19
9. Schwartz M. A., Horwitz A. R., Integrating adhesion, protrusion, and contraction during cell migration. Cell 2006 125 7 1223 1225 2-s2.0-33745245543 10.1016/j.cell.2006.06.015 (Pubitemid 43929100)
10. Obara K., Nishizawa S., Koide M., Nozawa K., Mitate A., Ishikawa T., Nakayama K., Interactive role of protein kinase C- δ with Rho-kinase in the development of cerebral vasospasm in a canine two-hemorrhage model. Journal of Vascular Research 2005 42 1 67 76 2-s2.0-13244273762 10.1159/000083093 (Pubitemid 40187044)
11. Watanabe Y., Faraci F. M., Heistad D. D., Activation of rho-associated kinase during augmented contraction of the basilar artery to serotonin after subarachnoid hemorrhage. The American Journal of Physiology-Heart and Circulatory Physiology 2005 288 6 2653 2658 2-s2.0-19344371353 10.1152/ajpheart.00923.2004 (Pubitemid 40720642)
12. Sato M., Tani E., Fujikawa H., Kaibuchi K., Involvement of Rho-kinase-mediated phosphorylation of myosin light chain in enhancement of cerebral vasospasm. Circulation Research 2000 87 3 195 200 2-s2.0-0033879562 (Pubitemid 30626426)
13. Funakoshi Y., Ichiki T., Shimokawa H., Egashira K., Takeda K., Kaibuchi K., Takeya M., Yoshimura T., Takeshita A., Rho-kinase mediates angiotensin II-induced monocyte chemoattractant protein-1 expression in rat vascular smooth muscle cells. Hypertension 2001 38 1 100 104 2-s2.0-0035571072 (Pubitemid 34224779)
14. Higashi M., Shimokawa H., Hattori T., Hiroki J., Mukai Y., Morikawa K., Ichiki T., Takahashi S., Takeshita A., Long-term inhibition of Rho-Kinase suppresses angiotensin II-induced cardiovascular hypertrophy in Rats in vivo: effect on endothelial NAD(P)H oxidase system. Circulation Research 2003 93 8 767 775 2-s2.0-0142120102 10.1161/01.RES.0000096650.91688.28 (Pubitemid 37288672)
15. Loirand G., Guérin P., Pacaud P., Rho kinases in cardiovascular physiology and pathophysiology. Circulation Research 2006 98 3 322 334 2-s2.0-33646763902 10.1161/01.RES.0000201960.04223.3c
16. Rikitake Y., Kim H. H., Huang Z., Seto M., Yano K., Asano T., Moskowitz M. A., Liao J. K., Inhibition of Rho kinase (ROCK) leads to increased cerebral blood flow and stroke protection. Stroke 2005 36 10 2251 2257 2-s2.0-26444518165 10.1161/01.STR.0000181077.84981.11 (Pubitemid 41429255)
17. Ishiko K., Sakoda T., Akagami T., Naka T., Doi T., Tsujino T., Masuyama T., Ohyanagi M., Hyperglycemia induced cell growth and gene expression via the serum response element through rhoa and rho-kinase in vascular smooth muscle cells. Preparative Biochemistry and Biotechnology 2010 40 2 139 151 2-s2.0-77749280011 10.1080/10826060903558927
18. Olson M. F., Applications for ROCK kinase inhibition. Current Opinion in Cell Biology 2008 20 2 242 248 2-s2.0-41749091574 10.1016/j.ceb.2008.01.002
19. Ishizaki T., Uehata M., Tamechika I., Keel J., Nonomura K., Maekawa M., Narumiya S., Pharmacological properties of Y-27632, a specific inhibitor of rho- associated kinases. Molecular Pharmacology 2000 57 5 976 983 2-s2.0-0034017744 (Pubitemid 30253382)
20. Vellimana A. K., Milner E., Azad T. D., Harries M. D., Zhou M. L., Gidday J. M., Han B. H., Zipfel G. J., Endothelial nitric oxide synthase mediates endogenous protection against subarachnoid hemorrhage-induced cerebral vasospasm. Stroke 2011 42 3 776 782 2-s2.0-79952072187 10.1161/STROKEAHA.110. 607200
21. Pagiatakis C., Gordon J. W., Ehyai S., McDermott J. C., A novel RhoA/ROCK-CPI-17-MEF2C signaling pathway regulates vascular smooth muscle cell gene expression. Journal of Biological Chemistry 2012 287 11 8361 8370 2-s2.0-84858061109 10.1074/jbc.M111.286203
22. Longo L. D., Zhao Y., Long W., Miguel C., Windemuth R. S., Cantwell A.-M., Nanyonga A. T., Saito T., Zhang L., Dual role of PKC in modulating pharmacomechanical coupling in fetal and adult cerebral arteries. The American Journal of Physiology-Regulatory Integrative and Comparative Physiology 2000 279 4 R1419 R1429 2-s2.0-0033681545
23. Somlyo A. P., Somlyo A. V., Signal transduction through the RhoA/Rho-kinase pathway in smooth muscle. Journal of Muscle Research and Cell Motility 2004 25 8 613 615 2-s2.0-17644378712 (Pubitemid 40562022)
24. Mori K., Yamamoto T., Miyazaki M., Hara Y., Aiko Y., Koike N., Sakamoto S., Nakao Y., Esaki T., Optimal cerebrospinal fluid magnesium ion concentration for vasodilatory effect and duration after intracisternal injection of magnesium sulfate solution in a canine subarachnoid hemorrhage model. Journal of Neurosurgery 2011 114 4 1168 1175 2-s2.0-79953706628 10.3171/2010.10.JNS10866
25. Muroi C., Burkhardt J. K., Hugelshofer M., Seule M., Mishima K., Keller E., Magnesium and the inflammatory response: potential pathophysiological implications in the management of patients with aneurysmal subarachnoid hemorrhage? Magnesium Research 2012 25 2 64 71
26. +-ATPase and neuroprotective effects against ischemic stroke. Acta Pharmacologica Sinica 2007 28 5 609 615 2-s2.0-34247874665 10.1111/j.1745-7254.2007.00544.x (Pubitemid 46691096)
27. Deng J. T., Sutherland C., Brautigan D. L., Eto M., Walsh M. P., Phosphorylation of the myosin phosphatase inhibitors, CPI-17 and PHI-1, by integrin-linked kinase. Biochemical Journal 2002 367 2 517 524 2-s2.0-0037109063 10.1042/BJ20020522 (Pubitemid 35216828)
28. Han J. Y., Fan J. Y., Horie Y., Miura S., Cui D. H., Ishii H., Hibi T., Tsuneki H., Kimura I., Ameliorating effects of compounds derived from Salvia miltiorrhiza root extract on microcirculatory disturbance and target organ injury by ischemia and reperfusion. Pharmacology and Therapeutics 2008 117 2 280 295 2-s2.0-38349123913 10.1016/j.pharmthera.2007.09.008
29. Park W. S., Son Y. K., Han J., Kim N., Ko J. H., Bae Y. M., Earm Y. E., Staurosporine inhibits voltage-dependent K+ current through a PKC-independent mechanism in isolated coronary arterial smooth muscle cells. Journal of Cardiovascular Pharmacology 2005 45 3 260 269 2-s2.0-14744273136 10.1097/01.fjc.0000154370.57789.fe (Pubitemid 40328149)
30. Lee Y. J., Kang D. G., Kim J. S., Lee H. S., Effect of Buddleja officinalis on high-glucose-induced vascular inflammation in human umbilical vein endothelial cells. Experimental Biology and Medicine 2008 233 6 694 700 2-s2.0-46449130105 10.3181/0710-RM-286
31. Iwabuchi S., Yokouchi T., Hayashi M., Uehara H., Ueda M., Samejima H., Intra-arterial administration of fasudil hydrochloride for vasospasm following subarachnoid hemorrhage-analysis of time-density curve with digital subtraction angiography. Neurologia Medico-Chirurgica 2006 46 11 535 539 2-s2.0-33947143724 10.2176/nmc.46.535